501 filings
Page 17 of 26
425
cvwr7skwxru
19 Feb 15
Business combination disclosure
12:00am
424B5
g9sxz4g
19 Feb 15
Prospectus supplement for primary offering
12:00am
S-3ASR
4kt8q 0q6nnw
19 Feb 15
Automatic shelf registration
12:00am
424B5
6vnrgppx0syblu
19 Feb 15
Prospectus supplement for primary offering
12:00am
8-K
6bplvrtn58wof sr
19 Feb 15
Regulation FD Disclosure
12:00am
8-K
fiei7ui
19 Feb 15
Other Events
12:00am
425
98p4ruwsl0v
19 Feb 15
Business combination disclosure
12:00am
425
aw5k9215r07ro8rq
18 Feb 15
Business combination disclosure
12:00am
8-K
viaz6p p8hsiw
18 Feb 15
Results of Operations and Financial Condition
12:00am
8-K
mn4ehl cb5r
18 Feb 15
Actavis Announces Intention to Adopt “Allergan” Corporate Name
12:00am
425
9crfqxe3svy
18 Feb 15
Business combination disclosure
12:00am
425
783bfsqxrbqeu dei
18 Feb 15
Business combination disclosure
12:00am
425
ol99kxw
13 Feb 15
Business combination disclosure
12:00am
425
gipa7 9x8n57n41tlqp
11 Feb 15
Business combination disclosure
12:00am
425
boqsgepmdky0
11 Feb 15
Business combination disclosure
12:00am
425
ulu152t
11 Feb 15
Business combination disclosure
12:00am
425
9pmu x37j4
10 Feb 15
Business combination disclosure
12:00am
8-K
1o8sufzlr 1yv7i9o
10 Feb 15
Actavis to Divest Rights to Branded Respiratory Portfolio in the U.S. and Canada to AstraZeneca
12:00am
425
kq9e2cqeb
10 Feb 15
Business combination disclosure
12:00am